Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 2Vomiting 1Pancreatic Neoplasms 1Neoplasms 1Nausea 1Diarrhea 1Constipation 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Breast Neoplasms 1

Interventions

lenvatinib 16Bevacizumab 14sintilimab 11tislelizumab 9apatinib 8regorafenib 6donafenib 6camrelizumab 5atezolizumab 4Immune Checkpoint Inhibitors 4Hepatectomy 4durvalumab 3Radiosurgery 3Capecitabine 3spartalizumab 2pembrolizumab 2cabozantinib 2anlotinib 2Specimen Handling 2Oxaliplatin 2Observation 2Magnetic Resonance Spectroscopy 2Injections 2Immunotherapy 2Folfox protocol 2Fecal Microbiota Transplantation 2Electroporation 2Blood Specimen Collection 2ursodoxicoltaurine 1tremelimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Hepatocellular × Fecal Microbiota Transplantation × Clear all
NCT07463248 2026-03-11

PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy

West China Hospital

Phase 2 Not yet recruiting
64 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06643533 2024-10-16

Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)

Fujian Provincial Hospital

Not yet recruiting
15 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡